- Home
- NRO vs CYBN Comparison
NRO vs CYBN Comparison
Compare NRO & CYBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRO
- CYBN
- Stock Information
- Founded
- NRO 2003
- CYBN 2019
- Country
- NRO United States
- CYBN Canada
- Employees
- NRO N/A
- CYBN N/A
- Industry
- NRO Finance/Investors Services
- CYBN Pharmaceuticals and Biotechnology
- Sector
- NRO Finance
- CYBN Health Care
- Exchange
- NRO Nasdaq
- CYBN Nasdaq
- Market Cap
- NRO 156.7M
- CYBN 174.9M
- IPO Year
- NRO N/A
- CYBN N/A
- Fundamental
- Price
- NRO $3.19
- CYBN $7.71
- Analyst Decision
- NRO
- CYBN Strong Buy
- Analyst Count
- NRO 0
- CYBN 4
- Target Price
- NRO N/A
- CYBN $86.00
- AVG Volume (30 Days)
- NRO 239.4K
- CYBN 310.7K
- Earning Date
- NRO 01-01-0001
- CYBN 08-07-2025
- Dividend Yield
- NRO 11.41%
- CYBN N/A
- EPS Growth
- NRO N/A
- CYBN N/A
- EPS
- NRO N/A
- CYBN N/A
- Revenue
- NRO N/A
- CYBN N/A
- Revenue This Year
- NRO N/A
- CYBN N/A
- Revenue Next Year
- NRO N/A
- CYBN N/A
- P/E Ratio
- NRO N/A
- CYBN N/A
- Revenue Growth
- NRO N/A
- CYBN N/A
- 52 Week Low
- NRO $2.51
- CYBN $4.81
- 52 Week High
- NRO $3.45
- CYBN $13.88
- Technical
- Relative Strength Index (RSI)
- NRO 50.59
- CYBN 50.59
- Support Level
- NRO $3.15
- CYBN $7.50
- Resistance Level
- NRO $3.21
- CYBN $9.20
- Average True Range (ATR)
- NRO 0.04
- CYBN 0.56
- MACD
- NRO -0.00
- CYBN -0.12
- Stochastic Oscillator
- NRO 51.82
- CYBN 27.06
About NRO Neuberger Berman Real Estate Securities Income Fund Inc.
NEUBERGER BERMAN REAL ESTATE SECURITIES INCOME FUND INC is a closed-end management investment company that invests mainly in securities issued by real estate companies, including real estate investment trusts (REITs). Its primary objective is to gain high current income with capital appreciation being the second. Under normal market conditions, the Fund invests at least 90% of its total assets in income-producing common equity securities, preferred securities, convertible securities and non-convertible debt securities issued by real estate companies, including real estate investment trusts ("REITs").
About CYBN Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions.